Peter A. Kavsak

11.2k total citations · 3 hit papers
170 papers, 5.2k citations indexed

About

Peter A. Kavsak is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, Peter A. Kavsak has authored 170 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 123 papers in Cardiology and Cardiovascular Medicine, 44 papers in Radiology, Nuclear Medicine and Imaging and 23 papers in Surgery. Recurrent topics in Peter A. Kavsak's work include Acute Myocardial Infarction Research (102 papers), Cardiac Imaging and Diagnostics (40 papers) and Cardiac electrophysiology and arrhythmias (23 papers). Peter A. Kavsak is often cited by papers focused on Acute Myocardial Infarction Research (102 papers), Cardiac Imaging and Diagnostics (40 papers) and Cardiac electrophysiology and arrhythmias (23 papers). Peter A. Kavsak collaborates with scholars based in Canada, United States and United Kingdom. Peter A. Kavsak's co-authors include Jeffrey L. Wrana, Gerald H. Thomsen, Shirin Bonni, Carrie G. Causing, Richele K. Rasmussen, Allan S. Jaffe, Haitao Zhu, Andrew R. MacRae, Andrew Worster and Fred S. Apple and has published in prestigious journals such as Nature, Circulation and Journal of Clinical Oncology.

In The Last Decade

Peter A. Kavsak

158 papers receiving 5.1k citations

Hit Papers

Smad7 Binds to Smurf2 to Form an E3 Ubiquitin Ligase that... 1999 2026 2008 2017 2000 1999 2018 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Smad7 Binds to Smurf2 to Form an E3 Ubiquitin Ligase that Targets the TGFβ Receptor for Degradation
    2000 1.1k citations Peter A. Kavsak et al. profile →
  2. A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation
    1999 694 citations Peter A. Kavsak et al. profile →
  3. Clinical Laboratory Practice Recommendations for the Use of Cardiac Troponin in Acute Coronary Syndrome: Expert Opinion from the Academy of the American Association for Clinical Chemistry and the Task Force on Clinical Applications of Cardiac Bio-Markers of the International Federation of Clinical Chemistry and Laboratory Medicine
    2018 303 citations Robert H. Christenson, Allan S. Jaffe et al. Clinical Chemistry profile →

Peers

Peter A. Kavsak
Jing-fei Dong United States
Susan Manzi United States
Alexandre E. Voskuyl Netherlands
Yuji Ikari Japan
Laurence Jesel France
Philippe de Moerloose Switzerland
Jacob H. Rand United States
Joan Carles Reverter Spain
Eldad Ben‐Chetrit Israel
Oliver Hartmann Germany
Jing-fei Dong United States
Peter A. Kavsak
Citations per year, relative to Peter A. Kavsak Peter A. Kavsak (= 1×) peers Jing-fei Dong

Countries citing papers authored by Peter A. Kavsak

Since Specialization
Citations

This map shows the geographic impact of Peter A. Kavsak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter A. Kavsak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter A. Kavsak more than expected).

Fields of papers citing papers by Peter A. Kavsak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter A. Kavsak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter A. Kavsak. The network helps show where Peter A. Kavsak may publish in the future.

Co-authorship network of co-authors of Peter A. Kavsak

This figure shows the co-authorship network connecting the top 25 collaborators of Peter A. Kavsak. A scholar is included among the top collaborators of Peter A. Kavsak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter A. Kavsak. Peter A. Kavsak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Saeed, Nasir, Jørund Langørgen, Øyvind Skadberg, et al.. (2025). Analytical Error of Cardiac Troponin and Impact on the Performance of Accelerated Diagnostic Protocols in Patients with Acute Chest Pain. Clinical Chemistry. 71(12). 1243–1256.
4.
Kavsak, Peter A., et al.. (2024). Case – Biotin supplements interfering with prostate-specific antigen assays. Canadian Urological Association Journal. 18(11). E365–E367. 1 indexed citations
5.
Pond, Gregory R., Elham Ahmadi, Anand Swaminath, et al.. (2024). Growth differentiation factor 15 (GDF15) predicts relapse free and overall survival in unresected locally advanced non-small cell lung cancer treated with chemoradiotherapy. Radiation Oncology. 19(1). 155–155. 3 indexed citations
6.
Morris, Emily, et al.. (2024). Treatment of Subclinical Hyperthyroidism and Incident Atrial Fibrillation. Clinical Endocrinology. 102(3). 315–323.
7.
Kavsak, Peter A., Joshua O. Cerasuolo, David H. Kirkwood, et al.. (2024). High-Sensitivity Cardiac Troponin I for Long-Term Cardiovascular Risk Stratification in a Cancer Clinic Population. JACC CardioOncology. 6(1). 136–138. 2 indexed citations
8.
9.
Pickering, John W., Peter A. Kavsak, Robert H. Christenson, et al.. (2024). Determination of Clinically Acceptable Analytical Variation of Cardiac Troponin at Decision Thresholds. Clinical Chemistry. 70(7). 967–977. 6 indexed citations
10.
Kavsak, Peter A., Shawn Mondoux, Joshua O. Cerasuolo, et al.. (2021). Diagnostic Performance of Serial High-Sensitivity Cardiac Troponin Measurements in the Emergency Setting. Journal of Cardiovascular Development and Disease. 8(8). 97–97. 7 indexed citations
11.
Kavsak, Peter A., Lorna Clark, Janet Martin, et al.. (2021). Acute Phase Response and Non-Reproducible Elevated Concentrations with a High-Sensitivity Cardiac Troponin I Assay. Journal of Clinical Medicine. 10(5). 1014–1014. 7 indexed citations
12.
Kavsak, Peter A., Shawn Mondoux, Janet Martin, et al.. (2021). Disagreement between Cardiac Troponin Tests Yielding a Higher Incidence of Myocardial Injury in the Emergency Setting. Journal of Cardiovascular Development and Disease. 8(3). 31–31. 3 indexed citations
13.
Kavsak, Peter A., et al.. (2021). Effect of racing on cardiac troponin I concentration and associations with cardiac rhythm disturbances in Standardbred racehorses. Journal of Veterinary Cardiology. 35. 14–24. 2 indexed citations
14.
Kavsak, Peter A., Joshua O. Cerasuolo, Shawn Mondoux, et al.. (2020). Risk Stratification for Patients with Chest Pain Discharged Home from the Emergency Department. Journal of Clinical Medicine. 9(9). 2948–2948. 4 indexed citations
15.
Duceppe, Emmanuelle, Flávia K. Borges, Maria Tiboni, et al.. (2020). ASSOCIATION BETWEEN HIGH-SENSITIVITY TROPONIN I AND MAJOR CARDIOVASCULAR EVENTS AFTER NON-CARDIAC SURGERY. Journal of the American College of Cardiology. 75(11). 110–110. 3 indexed citations
16.
Belley‐Côté, Emilie P., André Lamy, P.J. Devereaux, et al.. (2019). Definitions of post-coronary artery bypass grafting myocardial infarction: variations in incidence and prognostic significance. European Journal of Cardio-Thoracic Surgery. 57(1). 168–175. 10 indexed citations
17.
Belley‐Côté, Emilie P., Richard Whitlock, Kimia Honarmand, et al.. (2019). The PROTROPIC feasibility study: prognostic value of elevated troponins in critical illness. Canadian Journal of Anesthesia/Journal canadien d anesthésie. 66(6). 648–657. 3 indexed citations
18.
Meisner, Allison, Kathleen F. Kerr, Heather Thiessen‐Philbrook, et al.. (2018). Development of biomarker combinations for postoperative acute kidney injury via Bayesian model selection in a multicenter cohort study. Biomarker Research. 6(1). 3–3. 5 indexed citations
19.
Belley‐Côté, Emilie P., Chirag R. Parikh, Colleen Shortt, et al.. (2016). Association of cardiac biomarkers with acute kidney injury after cardiac surgery: A multicenter cohort study. Journal of Thoracic and Cardiovascular Surgery. 152(1). 245–251.e4. 30 indexed citations
20.
Silverman, Michael, Donna L. Reynolds, Peter A. Kavsak, et al.. (2007). Use of an interferon-gamma based assay to assess bladder cancer patients treated with intravesical BCG and exposed to tuberculosis. Clinical Biochemistry. 40(12). 913–915. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jing-fei Dong Breakdown of academic impact, for papers by Susan Manzi Breakdown of academic impact, for papers by Alexandre E. Voskuyl Breakdown of academic impact, for papers by Yuji Ikari Breakdown of academic impact, for papers by Laurence Jesel Breakdown of academic impact, for papers by Philippe de Moerloose Breakdown of academic impact, for papers by Jacob H. Rand Breakdown of academic impact, for papers by Joan Carles Reverter Breakdown of academic impact, for papers by Eldad Ben‐Chetrit Breakdown of academic impact, for papers by Oliver Hartmann
Rankless by CCL
2026